CSPC Pharmaceutical Group’s Stock Price Drops to 5.70 HKD, Plummeting by 5.32%

CSPC Pharmaceutical Group (1093)

5.70 HKD -0.32 (-5.32%) Volume: 114.25M

CSPC Pharmaceutical Group’s stock price stands at 5.70 HKD, experiencing a drop of -5.32% this trading session with a trading volume of 114.25M. The stock’s Year-To-Date performance reveals a downward trend with a percentage change of -17.36%, indicating a significant impact on the stock market.

Latest developments on CSPC Pharmaceutical Group

CSPC Pharmaceutical Group has been making headlines recently with reports of steady growth and shareholder rewards. The company recently declared an interim dividend of HKD 0.16, showing their commitment to rewarding investors. These positive developments have likely contributed to the movements in CSPC Pharmaceutical Group‘s stock price today, as investors react to the company’s strong performance and commitment to shareholder value.

CSPC Pharmaceutical Group on Smartkarma

Analysts on Smartkarma, like Tina Banerjee, are bullish on CSPC Pharmaceutical Group (1093 HK) as the company reported steady growth in finished drugs in 2023. New products such as Mingfule, Yilouda, and Anfulike have driven sales ramp-up, with plans to launch 50 innovative drugs in the next five years. CSPC Pharmaceutical’s shares are trading at a low P/E of 11.3x, the lowest in the last five years, making them cheaper than peers. Additionally, the company offers an attractive dividend yield of 4%+.

A look at CSPC Pharmaceutical Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

When looking at the long-term outlook for CSPC Pharmaceutical Group, the company seems to be in a solid position. With a high score in Dividend and Growth, it indicates that the company is performing well in terms of providing returns to its shareholders and showing potential for future expansion. Additionally, with above average scores in Resilience and Momentum, CSPC Pharmaceutical Group demonstrates stability and a positive trend in its market performance.

CSPC Pharmaceutical Group Limited, a company known for manufacturing and selling pharmaceutical products such as vitamin C, antibiotics, and common generic drugs, seems to have a promising future ahead. With a focus on developing innovative drugs and antibiotics, the company is staying competitive in the industry. Overall, the Smartkarma Smart Scores reflect a positive outlook for CSPC Pharmaceutical Group, suggesting that it is a company worth keeping an eye on for potential investment opportunities.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma